Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
The Journal of Biological Chemistry
|
May 30, 1997
K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors
D B Whyte, P Kirschmeier, T N Hockenberry, et al.
The Journal of Antibiotics
|
April 1, 1993
A novel class of platelet activating factor antagonists from Phoma sp
M Chu, I Truumees, I Gunnarsson, et al.
Blood
|
February 27, 2001
Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia
D G Peters, R R Hoover, M J Gerlach, et al.
Chemical Research in Toxicology
|
November 18, 2000
Biological effects and mechanism of action of farnesyl transferase inhibitors
H R Ashar, L Armstrong, L J James, et al.
Cancer Research
|
December 22, 1999
Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models
L L Nielsen, B Shi, G Hajian, et al.
Molecular Carcinogenesis
|
January 21, 2000
A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse
C S Trempus, W R Bishop, F G Njoroge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 1999
Treatment of neoplastic meningitis with intrathecal temozolomide
J H Sampson, G E Archer, A T Villavicencio, et al.
The Biochemical Journal
|
December 15, 1991
Quantification of diradylglycerols: a reply
R A Borchardt, W R Bishop, S B Bocckino, et al.
The Journal of Biological Chemistry
|
April 11, 1997
Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I
F L Zhang, P Kirschmeier, D Carr, et al.
Bioorganic & Medicinal Chemistry
|
July 10, 1999
Atropisomeric trihalobenzocycloheptapyridine analogues provide stereoselective FPT inhibitors with antitumor activity
F G Njoroge, B Vibulbhan, W R Bishop, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
The Journal of Biological Chemistry
|
May 30, 1997
K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors
D B Whyte, P Kirschmeier, T N Hockenberry, et al.
The Journal of Antibiotics
|
April 1, 1993
A novel class of platelet activating factor antagonists from Phoma sp
M Chu, I Truumees, I Gunnarsson, et al.
Blood
|
February 27, 2001
Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia
D G Peters, R R Hoover, M J Gerlach, et al.
Chemical Research in Toxicology
|
November 18, 2000
Biological effects and mechanism of action of farnesyl transferase inhibitors
H R Ashar, L Armstrong, L J James, et al.
Cancer Research
|
December 22, 1999
Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models
L L Nielsen, B Shi, G Hajian, et al.
Molecular Carcinogenesis
|
January 21, 2000
A farnesyl transferase inhibitor suppresses TPA-mediated skin tumor development without altering hyperplasia in the ras transgenic Tg.AC mouse
C S Trempus, W R Bishop, F G Njoroge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 1999
Treatment of neoplastic meningitis with intrathecal temozolomide
J H Sampson, G E Archer, A T Villavicencio, et al.
The Biochemical Journal
|
December 15, 1991
Quantification of diradylglycerols: a reply
R A Borchardt, W R Bishop, S B Bocckino, et al.
The Journal of Biological Chemistry
|
April 11, 1997
Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I
F L Zhang, P Kirschmeier, D Carr, et al.
Bioorganic & Medicinal Chemistry
|
July 10, 1999
Atropisomeric trihalobenzocycloheptapyridine analogues provide stereoselective FPT inhibitors with antitumor activity
F G Njoroge, B Vibulbhan, W R Bishop, et al.
Page
of 6